Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
van Eerden RAG, de Boer NL, van Kooten JP, Bakkers C, Dietz MV, Creemers GM, Buijs SM, Bax R, de Man FM, Lurvink RJ, Diepeveen M, Brandt-Kerkhof ARM, van Meerten E, Koolen SLW, de Hingh IHJT, Verhoef C, Mathijssen RHJ, Burger JWA. van Eerden RAG, et al. Among authors: buijs sm. Br J Surg. 2023 Oct 10;110(11):1502-1510. doi: 10.1093/bjs/znad228. Br J Surg. 2023. PMID: 37467389 Clinical Trial.
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial.
Braal CL, Westenberg JD, Buijs SM, Abrams S, Mulder TAM, van Schaik RHN, Koolen SLW, Jager A, Mathijssen RHJ. Braal CL, et al. Among authors: buijs sm. Breast Cancer Res Treat. 2022 Aug;195(1):65-74. doi: 10.1007/s10549-022-06643-y. Epub 2022 Jul 16. Breast Cancer Res Treat. 2022. PMID: 35842520 Free PMC article. Clinical Trial.
The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer.
Buijs SM, van Dorst DCH, Kruip MJHA, van den Akker RFP, Cheung KL, Porrazzo R, Oomen-de Hoop E, Jager A, Koolen SLW, Versmissen J, Jan Danser AH, Versteeg HH, Bos MHA, Mathijssen RHJ. Buijs SM, et al. Biomed Pharmacother. 2024 Jan;170:115969. doi: 10.1016/j.biopha.2023.115969. Epub 2023 Dec 2. Biomed Pharmacother. 2024. PMID: 38042112 Free article.
CBD-oil as a potential solution in case of severe tamoxifen-related side effects.
Buijs SM, Braal CL, Buck SAJ, van Maanen NF, van der Meijden-Erkelens LM, Kuijper-Tissot van Patot HA, Hoop EO, Saes L, van den Boogerd SJ, Struik LEM, van Rossum-Schornagel QC, Mathijssen RHJ, Koolen SLW, Jager A. Buijs SM, et al. NPJ Breast Cancer. 2023 Aug 5;9(1):63. doi: 10.1038/s41523-023-00570-x. NPJ Breast Cancer. 2023. PMID: 37543688 Free PMC article.